Hyperbaric Oxygen Therapy as an Adjuvant for Radiotherapy and Chemotherapy toward Cancer Cell
DOI:
https://doi.org/10.30649/htmj.v19i1.79Keywords:
hyperbaric oxygen therapy, radiotherapy, chemotherapy, cancer cellAbstract
Background : Cancer is non-infectious disease that become world”s burden today. In order to support the main treatment for cancer, hyperbaric oxygen therapy can be an option to be adjuvant therapy. Goal of this research is to know the influence of hyperbaric oxygen therapy as an adjuvant to radiotherapy and chemotherapy at cancer cell.
Method : This research use literature review as a method. Journal that used in this research is international journal that indexed in scimago or national journal that indexed in sinta that published from 2016 up to 2021. This research is held from April 2021 – September 2021. Research has been done in Fakultas Kedokteran Universitas Hang Tuah Surabaya.
Results : In this research, 11 studies has been collected where 10 among them stated that hyperbaric oxygen therapy give an influence toward radiotherapy and chemotherapy at cancer cell, while 1 study show there are no influence at all toward radiotherapy and chemotherapy. There are limitations in this research where studies which reviewed have different instruments, design, and therapeutic dose, thus make this research difficult to conclude.
Conclusion : 10 from 11 studies show hyperbaric oxygen therapy vary in effect to radiotherapy and chemotherapy in cancer cell like effication, sensitivity, work, toxicity effect, and inhibition effect improvement, also improvement of survival rate at cancerous patient, while 1 study show hyperbaric oxygen therapy has no effect toward radiotherapy and chemotherapy.
References
Choudhury, R. (2018) ‘Hypoxia and hyperbaric oxygen therapy: A review’, International Journal of General Medicine, 11, pp. 431–442. doi: 10.2147/IJGM.S172460.
Graham, K. and Unger, E. (2018) ‘Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment’, International Journal of Nanomedicine, 13, pp. 6049–6058. doi: 10.2147/IJN.S140462.
Iyikesici, M. S. (2019) ‘Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer’, International Journal of Hyperthermia. Taylor & Francis, 36(1), pp. 446–455. doi: 10.1080/02656736.2019.1589584.
Iyikesici, Mehmet Salih (2020) ‘Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer’, Complementary Medicine Research, 27(1), pp. 31–39. doi: 10.1159/000502135.
Iyikesici, M S (2020) ‘Survival Outcomes of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Advanced Gastric Cancer’, Nigerian Journal of Clinical Practice, 23(5), pp. 734–740. doi: 10.4103/njcp.njcp.
Jain, K. K. (2017) Textbook of Hyperbaric Medicine. Basel.
Jing, X. et al. (2019) ‘Role of hypoxia in cancer therapy by regulating the tumor microenvironment’, Molecular Cancer. Molecular Cancer, 18(1), pp. 1–15. doi: 10.1186/s12943-019-1089-9.
Kementrian Kesehatan RI (2019) ‘InfoDATIN Beban Kanker di Indonesia’. Jakarta Selatan, p. 16.
Mahdi, Hariyanto et.al (2018) Buku Ajar Ilmu Kesehatan Penyelaman dan Hiperbarik. Surabaya: LAKESLA.
Martin, S., Prise, K. M. and Hill, M. A. (2019) ‘Tumor Oxygenation and Cancer Therapy—Then and Now’, British Journal of Radiology, 92(1093), pp. 1–12. doi: 10.1259/bjr.20189005.
Mast, J. M. and Kuppusamy, P. (2018) ‘Hyperoxygenation as a therapeutic supplement for treatment of triple negative breast cancer’, Frontiers in Oncology, 8(NOV), pp. 1–9. doi: 10.3389/fonc.2018.00527.
Mattiuzzi, C. and Lippi, G. (2019) ‘Current cancer epidemiology’, Journal of Epidemiology and Global Health, 9(4), pp. 217–222. doi: 10.2991/jegh.k.191008.001.
Moen, I. and Stuhr, L. E. B. (2012) ‘Hyperbaric oxygen therapy and cancer - A review’, Targeted Oncology, 7(4), pp. 233–242. doi: 10.1007/s11523-012-0233-x.
Qi, Y. et al. (2017) ‘Effects of hyperbaric oxygen treatment on gastric cancer cell line SGC7901’, Biomedical Reports, 6(4), pp. 475–479. doi: 10.3892/br.2017.869.
Qian, C. et al. (2018) ‘The efficacy and tolerance of high pressure oxygen combined with chemotherapy in postoperative patients with advanced gastric cancer’, Translational Cancer Research, 7(3), pp. 489–494. doi: 10.21037/tcr.2018.04.16.
Sletta, K. Y. et al. (2017) ‘Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts’, PLoS ONE, 12(8). doi: 10.1371/journal.pone.0183254.
Snyder, H. (2019) ‘Literature review as a research methodology: An overview and guidelines’, Journal of Business Research. Elsevier, 104(March), pp. 333–339. doi: 10.1016/j.jbusres.2019.07.039.
Sung, H. et al. (2021) ‘Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries’, CA: A Cancer Journal for Clinicians, 71(3), pp. 209–249. doi: 10.3322/caac.21660.
Wang, H. et al. (2019) ‘Hypoxic radioresistance: Can ROS be the key to overcome it?’, Cancers, 11(1), pp. 1–23. doi: 10.3390/cancers11010112.
World Health Organization (2020a) ‘Cancer’. New York, p. 5. Available at: https://www.who.int/.
World Health Organization (2020b) ‘Global Cancer Observatory’. New York, p. 2. Available at: http://www.iarc.fr/.
World Health Organization (2020c) ‘The Global Cancer Observatory’. New York, p. 2. Available at: http://www.iarc.fr/.
Xie, Y. et al. (2018) ‘Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2/M phase arrest’, Nanomedicine, 13(8), pp. 887–898. doi: 10.2217/nnm-2017-0395.
Yahara, K. et al. (2017) ‘Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma’, Journal of Radiation Research, 58(3), pp. 351–356. doi: 10.1093/jrr/rrw105.
Zembrzuska, K., Ostrowski, R. P. and Matyja, E. (2019) ‘Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro’, Oncology Reports, 41(5), pp. 2703–2716. doi: 10.3892/or.2019.7064.
Zeng, X. et al. (2019) ‘Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma’, Journal of Nanobiotechnology. BioMed Central, 17(1), pp. 1–12. doi: 10.1186/s12951-019-0483-1.
